DE69821984D1 - Zubereitung enthaltend eine molekulardispersion mit erhöhter bioverfügbarkeit - Google Patents

Zubereitung enthaltend eine molekulardispersion mit erhöhter bioverfügbarkeit

Info

Publication number
DE69821984D1
DE69821984D1 DE69821984T DE69821984T DE69821984D1 DE 69821984 D1 DE69821984 D1 DE 69821984D1 DE 69821984 T DE69821984 T DE 69821984T DE 69821984 T DE69821984 T DE 69821984T DE 69821984 D1 DE69821984 D1 DE 69821984D1
Authority
DE
Germany
Prior art keywords
preparation contains
increased bioavailability
molecular dispersion
dispersion
molecular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69821984T
Other languages
English (en)
Other versions
DE69821984T2 (de
Inventor
A Sangekar
I Lee
A Nomeir
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DE69821984D1 publication Critical patent/DE69821984D1/de
Publication of DE69821984T2 publication Critical patent/DE69821984T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
DE69821984T 1997-12-22 1998-12-17 Zubereitung enthaltend eine molekulardispersion mit erhöhter bioverfügbarkeit Expired - Lifetime DE69821984T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99716897A 1997-12-22 1997-12-22
US997168 1997-12-22
PCT/US1998/026218 WO1999032118A1 (en) 1997-12-22 1998-12-17 Molecular dispersion composition with enhanced bioavailability

Publications (2)

Publication Number Publication Date
DE69821984D1 true DE69821984D1 (de) 2004-04-01
DE69821984T2 DE69821984T2 (de) 2004-12-30

Family

ID=25543717

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69821984T Expired - Lifetime DE69821984T2 (de) 1997-12-22 1998-12-17 Zubereitung enthaltend eine molekulardispersion mit erhöhter bioverfügbarkeit

Country Status (28)

Country Link
EP (1) EP1039908B1 (de)
JP (2) JP2001526227A (de)
KR (1) KR100597331B1 (de)
CN (1) CN1116039C (de)
AR (1) AR017436A1 (de)
AT (1) ATE260105T1 (de)
AU (1) AU761994C (de)
BR (1) BR9813728A (de)
CA (1) CA2315685C (de)
CO (1) CO4970793A1 (de)
CZ (1) CZ295956B6 (de)
DE (1) DE69821984T2 (de)
DK (1) DK1039908T3 (de)
ES (1) ES2214757T3 (de)
HK (1) HK1027040A1 (de)
HU (1) HU229052B1 (de)
ID (1) ID28304A (de)
IL (1) IL136460A0 (de)
MY (1) MY126580A (de)
NO (1) NO327383B1 (de)
NZ (1) NZ504834A (de)
PE (1) PE20000012A1 (de)
PL (1) PL192423B1 (de)
PT (1) PT1039908E (de)
SK (1) SK285662B6 (de)
TW (1) TW527196B (de)
WO (1) WO1999032118A1 (de)
ZA (1) ZA9811592B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
ES2333645T3 (es) 2001-06-22 2010-02-25 Bend Research, Inc. Composiciones farmaceuticas de dispersiones de medicamentos y polimeros neutros.
EP1492508A4 (de) * 2002-03-04 2009-05-06 Teva Pharma Dosierformen mit kontrollierter freisetzung
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
PT103661B (pt) 2007-02-23 2010-09-07 Hovione Farmaciencia S A Processo de preparação de minociclina base cristalina
WO2008136394A1 (ja) * 2007-04-27 2008-11-13 Ajinomoto Co., Inc. ラクタム化合物の製造方法及びその製造中間体
US8835635B2 (en) * 2012-06-05 2014-09-16 Symed Labs Limited Amorphous form of vilazodone hydrochloride substantially free of crystalline forms

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden
EP0214092A1 (de) * 1985-08-08 1987-03-11 Ciba-Geigy Ag Absorption von psychoaktiven 2-Aryl-pyrazoloquinolinen in Form einer festen Molekulardispersion in Polyvinylpyrrolidon
JP3722293B2 (ja) * 1991-12-18 2005-11-30 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 新規な薬学的固体分散物
JPH0848632A (ja) * 1994-08-08 1996-02-20 Kanebo Ltd エトポシドを含有する固形組成物および固形製剤
NZ326035A (en) * 1995-12-22 2000-01-28 Schering Corp Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases
WO1998000113A1 (en) * 1996-06-28 1998-01-08 Schering Corporation Solid solution of an antifungal agent with enhanced bioavailability

Also Published As

Publication number Publication date
KR20010033397A (ko) 2001-04-25
JP2010059212A (ja) 2010-03-18
HUP0100850A3 (en) 2002-12-28
CA2315685C (en) 2008-02-05
KR100597331B1 (ko) 2006-07-10
CZ20002304A3 (cs) 2001-04-11
TW527196B (en) 2003-04-11
ZA9811592B (en) 1999-06-17
PL341344A1 (en) 2001-04-09
CO4970793A1 (es) 2000-11-07
IL136460A0 (en) 2001-06-14
CN1116039C (zh) 2003-07-30
ES2214757T3 (es) 2004-09-16
BR9813728A (pt) 2000-10-10
AR017436A1 (es) 2001-09-05
DE69821984T2 (de) 2004-12-30
PE20000012A1 (es) 2000-01-18
NO20003235L (no) 2000-07-27
JP2001526227A (ja) 2001-12-18
NO327383B1 (no) 2009-06-22
CN1282245A (zh) 2001-01-31
SK285662B6 (sk) 2007-05-03
MY126580A (en) 2006-10-31
DK1039908T3 (da) 2004-05-03
AU1814399A (en) 1999-07-12
EP1039908A1 (de) 2000-10-04
HUP0100850A2 (hu) 2001-10-28
AU761994B2 (en) 2003-06-12
CA2315685A1 (en) 1999-07-01
ID28304A (id) 2001-05-10
EP1039908B1 (de) 2004-02-25
PL192423B1 (pl) 2006-10-31
ATE260105T1 (de) 2004-03-15
CZ295956B6 (cs) 2005-12-14
SK8962000A3 (en) 2001-07-10
WO1999032118A1 (en) 1999-07-01
AU761994C (en) 2004-01-08
HK1027040A1 (en) 2001-01-05
HU229052B1 (en) 2013-07-29
NZ504834A (en) 2001-12-21
PT1039908E (pt) 2004-06-30
NO20003235D0 (no) 2000-06-21

Similar Documents

Publication Publication Date Title
DE59811426D1 (de) Pigmentpräparation
ATE255883T1 (de) Fungizide mittel mit verbesserter bioverfügbarkeit
FR2763699B1 (fr) Detecteur-optoelectronique
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
DE69827870D1 (de) Drebohrmeissel mit beweglichen Formation-eingreifenden Elementen
NO20001776D0 (no) Medikamenter
FR2761532B1 (fr) Antenne-reseau a dipoles a microrubans a cavites
DE122004000018I1 (de) 4"-Substitutierte-9-Deoxo-9A-Aza-9A-Homoerythromycin a Derivate.
DK0966477T3 (da) 3'-N-oxid, 3'-N-dimethylamin, 9-oxim-erythromycin A-derivater
DE69818878D1 (de) Copolyester mit verbesserter Klarheit
DE69829373D1 (de) Polymerisationsverfahren
NO20000014D0 (no) Grohemmende polymerer
DE69813694D1 (de) Polymerisationsverfahren
DE69821984D1 (de) Zubereitung enthaltend eine molekulardispersion mit erhöhter bioverfügbarkeit
DE69805646T2 (de) Eine kondensationspolymer enthaltende photoresistzusammensetzung
NO995039D0 (no) Gastrisk bibeholdt farmasöytisk preparat
DE69839129D1 (de) Polymerisationsverfahren
DE59810608D1 (de) Stapelvorrichtung
NO993662D0 (no) Polymerer
DE69816006D1 (de) Reissverschluss mit Ausrichtungsmarken
DE69826832D1 (de) Polymerisationsverfahren
FR2758387B1 (fr) Four-tunnel a elements infra-rouge
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on

Legal Events

Date Code Title Description
8364 No opposition during term of opposition